Table 6 Multivariate predictors of PFS and OS for patients with LGGsa
From: Expression of HLA-DR genes in gliomas: correlation with clinicopathological features and prognosis
Variables | PFS | OS | ||||
|---|---|---|---|---|---|---|
Risk ratio | 95% CI | p-value | Risk ratio | 95% CI | p-value | |
HLA-DR score | 1.121 | 1.004-1.251 | 0.042 | 1.141 | 1.016-1.282 | 0.025 |
Age > 40 | 1.380 | 0.715-2.663 | 0.337 | 1.659 | 0.799-3.442 | 0.174 |
Sex (male) | 1.237 | 0.636-2.406 | 0.531 | 1.141 | 0.563-2.312 | 0.715 |
Pathology (Astrocytic) | 1.004 | 0.503-2.002 | 0.991 | 0.833 | 1.211-4.075 | 0.636 |
Lesion side (left) | 0.918 | 0.478-1.762 | 0.797 | 1.210 | 0.602-2.432 | 0.593 |